Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Buck

Showing results (331-340 of 337) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 337 results.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Stroke|January 26, 2024
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled TrialTolulope T Sajobi, Olayinka I Arimoro, Ayoola Ademola, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Lancet (London, England)|February 24, 2020
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Bijoy K Menon, et al.
The New England Journal of Medicine|February 5, 2025
Endovascular Treatment of Stroke Due to Medium-Vessel OcclusionMayank Goyal, Johanna M Ospel, Aravind Ganesh, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Andrew M Demchuk, et al.
Journal of Extracellular Vesicles|January 15, 2019
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesClotilde Théry, Kenneth W Witwer, Elena Aikawa, et al.
Pageof 34

Showing results (331-340 of 337) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 337 results.
Lancet (London, England)|July 2, 2022
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trialBijoy K Menon, Brian H Buck, Nishita Singh, et al.
Stroke|January 26, 2024
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled TrialTolulope T Sajobi, Olayinka I Arimoro, Ayoola Ademola, et al.
Lancet (London, England)|May 20, 2024
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trialShelagh B Coutts, Sandeep Ankolekar, Ramana Appireddy, et al.
Lancet (London, England)|February 24, 2020
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Bijoy K Menon, et al.
The New England Journal of Medicine|February 5, 2025
Endovascular Treatment of Stroke Due to Medium-Vessel OcclusionMayank Goyal, Johanna M Ospel, Aravind Ganesh, et al.
Lancet (London, England)|February 15, 2025
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trialMichael D Hill, Mayank Goyal, Andrew M Demchuk, et al.
Journal of Extracellular Vesicles|January 15, 2019
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelinesClotilde Théry, Kenneth W Witwer, Elena Aikawa, et al.
Pageof 34